Proliferation of SMCs is essential for repair of injured arteries, but in excess can cause vascular obstruction leading to tissue ischaemia and/or infarction 14 . SMC expression of the atypical cadherin Fat1 is induced by both growth factor exposure and vascular injury; however, knockdown of Fat1 enhances SMC proliferation, and the Fat1 intracellular domain (Fat1 ICD), expressed as a chimaeric protein fused to the interleukin 2 receptor α -chain (denoted hereafter as Fat1-IL-2R), is sufficient to inhibit growth 15 . In addition, recent reports link FAT1 silencing and/or mutation to a spectrum of cancers 8,9 . To understand how Fat1 controls proliferation, we used tandem affinity purification (TAP) followed by peptide mass fingerprinting using matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry (TAP-MS) to identify
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Figure 1 | Fat1 fragments localize to SMC mitochondria and interact with inner mitochondrial membrane proteins. a, Analysis of 30 top-ranked TAP-MS-validated Fat1 ICD interactors. IMM and OMM, inner and outer mitochondrial membrane, respectively (see Extended Data Table 1 ). b, Mitochondrial cluster in bioinformatic analysis of TAP-MS data (see Extended Data Fig. 1a) . c, Fractionation of mouse aortic SMCs, followed by SDS-PAGE and immunoblotting. C, cytoplasmic; Mit, mitochondrial; Ms, microsomal; WL, whole-cell lysate. Arrowhead, full-length Fat1; bracket, Fat1 ICD species; red asterisk, mitochondrial-specific Fat1 ICD fragments; blue asterisk, non-specific signal. 
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proteins that interact with the Fat1 ICD. We noted that a surprisingly large fraction of candidate interactors associated with mitochondria, including several proteins that localize to the inner mitochondrial membrane (Fig. 1a , Extended Data Table 1 ); these observations were replicated in an unbiased independent bioinformatic analysis of the TAP-MS dataset (Fig. 1b, Extended Data Fig. 1a ).
We used a conditionally targeted mouse Fat1 allele (Fat1 loxP ) 11 and Cre-mediated recombination to inactivate Fat1 expression in SMCs (Extended Data Fig. 1b) . Cellular fractionation showed Fat1 fragments in the mitochondrial sample: immunoblotting using a Fat1 C-terminusdirected antiserum 15 identified multiple specific signals between ~ 60-100 kDa, including an ~ 60 kDa band seen only in whole-cell and mitochondrial fractions (Fig. 1c) . Confocal imaging of these cells showed Fat1 and mitochondrial co-localization (Fig. 1d) . Identification of multiple inner mitochondrial membrane proteins in our screen (Fig. 1a , Extended Data Fig. 1a , Extended Data Table 1) suggests that Fat1 may associate with respiratory complexes; indeed, traditional coimmunoprecipitation studies confirmed interaction of the Fat1 ICD with NDUFS3, a complex-I-specific subunit (Fig. 1e) , and with prohibitin, an important regulator of complex I stability and function 16 (Extended Data Fig. 1c) .
We then assessed growth and mitochondrial function. Resazurin (AlamarBlue) growth/viability assays were validated across a range of input cell numbers, and performed similarly for both wild-type and Fat1 KO cells (Extended Data Fig. 2a ). Evidence of higher proliferation in SMCs lacking Fat1 (Fig. 2a, Extended Data Fig. 2b ) was normalized by restoring Fat1 expression with Fat1-IL-2R (Extended Data Fig. 2b ). In assays of mitochondrial respiration using extracellular flux (Seahorse) analysis, Fat1 KO SMCs exhibited higher baseline and maximal oxygen consumption rates (OCRs) compared to wild type (Fig. 2b, Extended Data Fig. 2c) , with equal coupling efficiency (Extended Data Fig. 2d ). Coupling efficiency reflects how effectively respiratory activity is translated into ATP production 17 , so higher ATPlinked oxygen consumption in Fat1 KO SMCs indicates that these cells generate more ATP. Net ATP levels in wild-type and Fat1 KO SMCs were similar (Extended Data Fig. 2e ), which in turn suggests that consumption of ATP in Fat1 KO SMCs is also increased. Reactive oxygen species, which also result from mitochondrial respiration, were present at similar levels under standard conditions, but were higher in Fat1 KO cells after exposure to H 2 O 2 (Extended Data Fig. 2f ), suggesting a partially depleted capacity to buffer or inactivate reactive oxygen species when Fat1 is absent. Aspartate, a metabolite essential for macromolecular synthesis and cell proliferation, and a third key product of respiration 18, 19 , was present at higher levels in Fat1 KO SMCs (Fig. 2c) . Mitochondrial respiration is essential for cell growth 18, 19 , including that of SMCs 20 , so we tested its role in the increased growth of Fat1 KO cells. Limiting respiration by either pharmacologic or genetic interference targeting complex I did not compromise wild-type cell growth, but suppressed the growth advantage of Fat1 KO cells (Fig. 2d , Extended Data Fig. 3a-c ). These studies suggest that physiologic Fat1 expression modulates SMC growth by restraining mitochondrial respiration, and that further limits on respiration in wild-type cells have no repercussion. By contrast, when Fat1 is absent, the corresponding loss of this restraint increases SMC growth. Overall, these in vitro studies identify Fat1 as an important suppressor of SMC growth, and show that potentiation of growth in the absence of Fat1 depends on increased respiration.
Respiration can be affected by changes in mitochondrial structure, mass, and/or dynamics, but mitochondria from wild-type and Fat1 KO SMCs did not exhibit major ultrastructural differences by electron microscopy (Extended Data Fig. 4a-f ). Likewise, we found no evidence for changes in (1) mitochondrial mass, on the basis of the levels of several respiratory chain subunits (Extended Data Fig. 4g ), (2) mitochondrial biogenesis and autophagy, on the basis of expression of regulators of these respective processes 21 (Extended Data Fig. 4h-j) , or (3) mitochondrial dynamics, as reflected in fusion or fission gene expression (Extended Data Fig. 4h, k) . Failing to identify differences in mitochondrial structure, mass, or turnover that could explain the increased respiration in Fat1 KO SMCs, we surmised that loss of Fat1 might directly affect respiratory chain activity.
To assess this possibility, we tested if the Fat1 ICD was sufficient to control respiration. Expression of Fat1-IL-2R-which inhibits SMC growth 15 -limited respiration in Fat1 KO SMCs (Fig. 3a) , and yielded fragments in the mitochondrial fraction similar in size to endogenous mitochondrial Fat1 species (Extended Data Fig. 5a ), but this fusion protein may also localize to other subcellular compartments. We generated and validated a mitochondria-targeted Fat1 ICD (Fat1 Data Fig. 5a, d ), the extent of OCR repression achieved was similar, perhaps indicating that only a subset of the Fat1-IL-2R-derived fragments are active in this capacity. To localize this effect within the respiratory chain, we assessed the activities of isolated respiratory complexes. Complexes I and II, but not IV or V, were more active in the absence of Fat1 (Fig. 3b, c, Extended Data Fig. 6a, b) . Moreover, Fat1 ICD species of ~ 60-100 kDa were observed in association with immunocaptured complex I, II and V, but not complex IV (Fig. 3d, Extended  Data Fig. 6c ). To see if Fat1 affects respiratory complex integrity, we looked at intact mitochondrial complexes by blue native (BN)-PAGE analysis and found that in Fat1 KO SMCs, complex I incorporation into supercomplexes is increased, without a significant change in the levels of native complex I (Fig. 3e, f, Extended Data Fig. 6d ). It has been proposed that supercomplex conformation facilitates electron transfer without increasing production of reactive oxygen species 22, 23 ; however, the factors regulating supercomplex assembly are largely unknown.
Orthogonal resolution of BN gels under denaturing conditions indicated a shift of complex I subunits towards supercomplex conformations in Fat1-deficient SMCs and no major differences in native complex II (Extended Data Figs 6e, 7). We observed ~ 60-100-kDa Fat1 species co-migrating with complex I, II, III, and V, but not complex IV. Notably, a subset of these species also co-migrated with a supercomplex containing at least complexes I and III (Extended Data Fig. 6e ). These findings suggest that Fat1 limits SMC mitochondrial respiration by repressing complex I and II activities, and by opposing the incorporation of complex I into supercomplex structures.
To assess Fat1 relevance to clinical vascular disease, we examined segments of diseased post-mortem human arteries adjacent to sites of prior stent placement. FAT1 expression coincided in many areas with ACTA2, a marker of SMCs (Fig. 4a) . As it did in mouse SMCs, FAT1 in cultured human aortic SMCs (HASMCs) co-localized with mitochondria (Fig. 4b) . Moreover, knockdown of FAT1 in HASMCs increased both cell proliferation (Extended Data Fig. 8a -c) and basal and maximal mitochondrial respiration (Extended Data Fig. 8d, e SMKO mice showed markedly higher medial SMC hyperplasia and neointimal growth ( Fig. 4c-f) , increased phospho-histone H3 and cyclin D1 (Fig. 4g) , and increased staining for nitrotyrosine, a marker of increased superoxide stress (Extended Data Fig. 9c ). Moreover, SMCs from injured Fat1 SMKO vessels exhibited higher OCRs than those from injured control vessels (Fig. 4h, i . This last finding contrasts notably with the increased respiratory activity that we find with Fat1 inactivation, and probably partly reflects the structural divergence between these cadherins 29 . Nevertheless, the finding that both Drosophila Fat and mammalian Fat1 participate in mitochondrial regulation is intriguing and perhaps suggests an ancient shared linkage between primordial cell surface proteins and control of mitochondrial function. Whether Fat4 is active in mitochondria, and how these distinct members of the Fat family might cooperate to regulate mitochondrial function, remain to be determined.
Although the factors or conditions that trigger Fat1 processing and translocation of C-terminal fragments to mitochondria have yet to be defined, our results suggest a relatively direct mechanism for sensing the extracellular milieu and relaying signals to mitochondria to control respiratory chain activity and thereby affect other key metabolic functions. This mechanism could potentially be targeted in hyperproliferative conditions in the cardiovascular system, as shown here, or in other scenarios. To this point, the loss or mutation of Fat1 (refs 8, 9) and the gain of Fat1 expression 10,30 have both been linked to different cancers. In addition, mutations in the FAT1 gene have recently been implicated in abnormal renal development 11 and skeletal muscle formation 12 , and FAT1 sequence variants have been associated with bipolar disorder, schizophrenia, and autism spectrum disorders 13 . The potential contribution of mitochondrial dysregulation in these divergent scenarios is an area for further study.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.
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Protein interaction studies. Tandem affinity purification and mass spectrometry (TAP-MS) was performed using an IL-2R-Fat1-ICD fusion protein 15 (Fat1-IL-2R) cloned into the pCTAP vector (240104, Agilent) to place tandem streptavidin and calmodulin binding peptides (SBP, CBP) at the C terminus of the chimaeric protein. A negative control construct included the IL-2R sequence, but not the Fat1 ICD. These constructs were transfected into 293T cells (ATCC), from which total protein lysates were sequentially purified with SBP and CBP beads (InterPlay TAP kit, Agilent). After gentle washing, purified protein complexes were eluted from CBP beads and concentrated (UFC500396, Amicon Ultra), resolved by SDS-PAGE, stained with Coomassie, and submitted for MS/MS analysis (Protein Core Facility, Columbia University) to identify Fat1 ICD associated proteins. MS/MS-validated proteins were scored on the basis of their abundance in the Fat1-IL-2R sample in comparison to the IL-2R control using the ProteoIQ software.
Bioinformatic analysis of the TAP-MS results addressed the 175 potential Fat1 ICD protein interactors with a MASCOT ratio (Fat1 ICD over control) greater than 2. To identify novel interactors, we used information on known proteinprotein interactions available in the STRING database 31 . We downloaded all proteins that interacted with the 175 candidate interactors at the lowest confidence level in the database (STRING scores greater than 0.15), and calculated the Page Rank for each node (protein) in the STRING network at different confidence levels (low, 0.15; medium, 0.40; high, 0.70; highest, 0.90) using the Perl module Graph::Centrality::Pagerank, available in the CPAN repository (http://www.cpan.org/). Nodes with high PageRank fractions refer to highly connected proteins more likely to be pulled down by chance. From the intersection of proteins with 'high' and 'highest' STRING confidence scores, we isolated 108 novel Fat1 ICD interactors (Page Rank cutoff of < 0.005) and performed enrichment analysis with the DAVID Bioinformatics Resource 32 . Results were plotted using the EnrichmentMap plugin 33 in Cytoscape 3.1 (ref. 34 ). Interaction of the Fat1 ICD and endogenous NDUFS3 was assessed using the IL-2R and Fat1-IL-2R plasmids in TAP-based co-immunoprecipitation and immunoblotting. To evaluate Fat1-prohibitin (PHB) interaction, PHB cDNA amplified by RT-PCR from mouse spleen RNA was cloned into pCS2-6XMyc vector to generate a C-terminally tagged PHB-Myc. DelN Fat1-ICD CMV13-Flag 35 and/ or PHB pCS2-6XMyc plasmids were transfected into 293T cells. Protein lysates (300 μ g) were pre-cleared with Protein G PLUS agarose beads (sc-2002, Santa Cruz) and mouse IgG1 isotype control (M075-3M2, MBL). PHB-Myc was captured with c-Myc beads (sc-40 AC, Santa Cruz), and co-immunoprecipitated proteins were eluted by boiling and assessed for c-Myc and Flag using immunoblotting.
Cell culture and imaging. Wild-type and Fat1
KO mouse aortic SMCs were isolated from aortas of 5-week-old control and Fat1 SMKO mice 11,24 by collagenase-elastase digestion 36 . SMCs were maintained in Dulbecco's modified eagle medium (DMEM) containing 20% fetal bovine serum (FBS), 1% l-glutamine, 100 U ml −1 penicillin, and 100 μ g ml −1 streptomycin, and were passaged every three to four days. Cells between passages two and five were used for experiments; these early passage cells were not tested for mycoplasma. To evaluate population growth using the AlamarBlue assay (BUF012A, BIO-RAD), 5,000 cells were plated per well of a 96-well plate and followed for up to 96 h. Absorbances at 570 nm and 600 nm were measured on a Synergy 2 microplate reader (BioTek). Reduction of AlamarBlue correlates with the number of viable cells, and was calculated according to the manufacturer's specifications and expressed as fold-change with respect to baseline. Where indicated, treatment with 0.02-20 μ M rotenone or DMSO (vehicle) was administered at 0 and 24 h. Human aortic smooth muscle cells (HASMCs, Clonetics) were maintained in Medium 199 supplemented as indicated for DMEM, and passaged every four to five days.
To assess proliferation, mouse SMCs were incubated with EdU for six hours before being fixed, permeabilized, and stained for EdU and total DNA (Hoechst stain), as advised by the manufacturer (C10337, ThermoFisher Scientific). Fluorescent signals (excitation:emission (Ex:Em) = 495:519 nm for EdU, 350:461 nm for Hoechst) were measured on a Synergy 2 microplate reader (BioTek), and EdU incorporation was expressed as the ratio of EdU to Hoechst signals. In some studies, wild-type and Fat1 KO cells were transfected with 25 nM of control or Ndufs3 small interfering RNA (siRNA) (sense sequence 5′ -GCAGAACCGUUUUGAGAUUTT-3′ ; s86598, Ambion) on 60 mm culture dishes using TransIT-X2 (MIR6000, Mirus). The following day, cells were transferred onto 96-well plates at 2,000 cells per well, and grown for an additional three days before EdU incorporation was measured. HASMCs were transfected with 12 nM of control or FAT1 siRNA (sense sequence 5′ -CAGCGAAUGUAACAGUACAtt-3′ ; s5035, Ambion) on 60 mm culture dishes using TransIT-X2 (MIR6000, Mirus). Two days after transfection, cells were transferred onto 96-well plates at 3,000 cells per well and grown for an additional two days before EdU assay.
Co-localization studies were performed as follows: SMCs were seeded onto glass coverslides, stained with 60 nM Mitotracker Red (M-7512, Life Technologies) for 40 min at 37 °C, fixed with 4% paraformaldehyde (PFA) in phosphate buffer saline (PBS) for 15 min at 37 °C, blocked overnight (0.2% milk, 2% normal goat serum, 0.1 M glycine, 2% BSA, and 0.15% Triton-X-100 in PBS), and stained for Fat1 using specific antisera 15 and Alexa Fluor 488 goat anti-rabbit IgG secondary antisera in 0.2% BSA in PBS. SMCs lacking Fat1 and omission of the primary antibody served as controls for signal specificity. Fluorescent signals were visualized using a 4-D spinning-disk confocal microscope (Perkin-Elmer) with a 40× (1.3 NA) objective attached to a digital camera (Orca ER; Hamamatsu). Images were analysed with the Image-J (v1.48v) software.
Electron micrography of wild-type and Fat1 KO SMCs was performed in the Albert Einstein College of Medicine Analytical Imaging Facility using standard fixation and imaging procedures. Micrographs were analysed using the Image-J (v1.48v) software. Mitochondrial studies. Cellular fractions highly enriched for mitochondria were isolated using the Qproteome Mitochondria Isolation Kit (37612, Qiagen). Cells were lysed and further disrupted by passing the lysate through a 26-gauge, bluntend needle, and mitochondria were isolated using differential centrifugation, followed by density gradient separation. Compartmental markers such as BiP and GAPDH (Fig. 1c, Extended Data Fig. 5c ) indicated efficient though not absolute fractionation of mitochondrial components.
Mitochondrial oxygen consumption rate (OCR) was measured using a XF96 Extracellular Flux Analyzer (Seahorse Biosciences) following manufacturer's instructions. Mouse SMCs were plated on a Seahorse 96-well assay plate at 5,000 cells per well, and tested in minimal assay media containing 5 mM glucose, 4 mM pyruvate, and 2 mM l-glutamine. The following drugs were injected to achieve the indicated final concentration: oligomycin (2 μ g ml −1 ), FCCP (3 μ M), and rotenone (2 μ M). Total protein was isolated from each well and quantified for normalization after the assay. When indicated, Fat1 KO SMCs were electroporated (Neon System, Life Technologies) with plasmids encoding Fat1-IL-2R, Fat1 mito , or empty pcDNA3.1 vector, immediately seeded at 6,000 cells per well onto Seahorse plates, and allowed to recover for three days before measuring OCR. To evaluate respiration in HASMCs, cells were transfected with 12 nM of control or FAT1 siRNA (s5035, Ambion) on six-well culture plates using TransIT-X2 (MIR6000, Mirus). Three days after transfection, HASMCs were re-plated onto Seahorse plates at 3,000 cells per well, and OCR was measured as described. To evaluate respiration in SMCs after vascular injury, ligated arteries and their uninjured counterparts were collected from control and Fat1 SMKO mice three days after arterial ligation using the collagenase-elastase method 36 , seeded on a Seahorse 96-well plate at 15,000 cells per well, and allowed to recover for ~ 80 h before OCR was measured. OCRs from validated mouse aortic SMC cultures were used to normalize and account for technical variability between experiments.
To target the Fat1 ICD to mitochondria, we assembled the Fat1 mito construct, which includes the first 58 amino acids (with the mitochondrial targeting sequence) of the mouse thioredoxin-2 protein (GenBank accession NM_019913) and amino acids 4,215-4,591 of mouse Fat1, and cloned it into the pcDNA3.1 expression vector. Mitochondria-specific localization of this fusion protein was confirmed by cellular fractionation (Qiagen) of SMCs and 293T cells, followed by SDS-PAGE and immunoblotting with Fat1 antisera 15 . ATP was measured using a bioluminetric assay (30020-1 Biotium, Inc.) in wild-type and Fat1 KO SMCs. Micromolar concentrations of ATP were calculated using a standard curve and normalized to percentage of AlamarBlue reduction as a surrogate for cell number to estimate net ATP levels per cell. Data were expressed as fold change respect to wild type.
Reactive oxygen species (ROS) levels were assessed by transfection of wildtype and Fat1 KO cells with a thiol redox-sensitive ratiometric sensor, reductionoxidation-sensitive GFP (roGFP, Addgene plasmid 49435) 37 using TransIT-X2 (MIR6000, Mirus). After two days, cells were imaged on CELLview glass bottom dishes (5662-7860Q, USA Scientific) containing buffer with divalent cations (125 mM NaCl, 5 mM KCl, 1 mM KH 2 PO 4 , 5 mM glucose, 10 mM NaHCO 3 , 1 mM MgCl 2 , 1 mM CaCl 2 , and 20 mM HEPES) at 37 °C 38 . Live cell images were acquired using IX81ZDC wide-field microscope (Olympus) and a single CoolsnapHQ2 (Photometrics) cooled CCD-camera on the bottom 100% throughput port of the microscope. For ratiometric determination of cellular ROS content, cells were sequentially imaged with a 40× magnification objective lens (Olympus; UIS2 40X DIC N/A 1.3) using excitation light from a 100 W Hg arc lamp and bandpass filter FF390/40 (Semrock) (targeting the 400 nm excitation peak of the oxidized form of roGFP) and bandpass filter ET470/40 (Chroma Technology) (targeting the 484 nm excitation peak of the reduced form of roGFP). Fluorescence emissions were detected through a bandpass filter ET525/50 (Chroma Technology). Neutral density filters of 10% to 25% transmission (ND 1.0-0.6) were routinely used to reduce the Letter reSeArCH intensity of the excitation light to prolong cell viability. The camera exposure times for 390 nm and 470 nm excitations and the respective emission detections at 525 nm were maintained at a 2:1 ratio to maximize the light collection within the dynamic range of the detector. Typically, this was on the order of 200-600 ms, depending on the expression levels of the roGFP probe in a cell. Cells were imaged at 10-s intervals for 5 min, and for an additional 15 min after stimulation with 50 μ M H 2 O 2 . Images were processed as previously described 39 . In brief, images were corrected for camera noise and for uneven illumination within the field of view, followed by background subtraction and a histogram-threshold-based masking. At each time point, processed images for each excitation wavelength were divided to obtain the ratiometric (390:470 nm) value, which was then expressed as fold increase above the average baseline (before H 2 O 2 stimulation) ratio.
Aspartate levels were measured using a colourimetric assay (ab102512 Abcam) in total cell lysates from wild-type and Fat1 KO SMCs. Data was corrected by subtracting the background as suggested by the manufacturer. Nanomoles of aspartate per sample were calculated using a standard curve and normalized to mg of protein per sample as a surrogate for cell number, and data were expressed as fold change respect to wild type.
Respiratory complex activities and Fat1-complex association were assessed as follows. Mitochondrial complex I activity was evaluated in wild-type and Fat1 KO SMCs using the complex I activity microplate assay kit (ab109721, Abcam) in accordance with the manufacturer's instructions. The rate of oxidation of NADH to NAD + was measured after immunocapturing complex I from 200 μ g of total protein lysate. Enzymatic (diaphorase) activity was calculated as the change in absorbance (1,000 × (optical density at 450 nm)) per minute (abbreviated as mOD/ min). Complex II activity was evaluated using the corresponding assay (ab109908, Abcam), measuring ubiquinol production after immunocapturing complex II from 100 μ g of total protein lysate, with enzymatic activity measured as a decrease in absorbance at 600 nm per minute (mOD/min). Complex IV activity was tested using the corresponding assay (ab109911, Abcam), with the rate of cytochrome C oxidation measured after immunocapturing complex IV from 70 μ g of total protein lysate, and enzymatic activity measured as a decrease in absorbance at 550 nm per minute (mOD per min). Complex V activity was measured in human aortic SMCs treated with control or FAT1 siRNA using the ATP synthase enzyme activity microplate assay kit (ab109714, Abcam). Hydrolysis of ATP to ADP and phosphate was measured after immunocapturing complex V from 90 μ g of total protein lysate. Enzymatic activity was measured as a decrease in absorbance at 340 nm per minute (mOD per min). Negative controls were run in every assay, a Synergy 2 microplate reader (BioTek) was used to measure absorbance, and data were expressed as fold-change respect to wild-type cells. After the enzymatic assays, plates were washed with PBS, and proteins were eluted from immunocaptured respiratory complexes by adding 10 μ l per well of RIPA buffer with protease inhibitors plus 6× Laemmli protein loading buffer, and incubating the plate at 85 °C for 10 min. Recovered proteins were studied by immunoblotting for Fat1 fragments and respiratory complex subunits.
Respiratory complex conformations were evaluated by blue native (BN)/SDS-PAGE. First dimension BN-PAGE was performed by solubilizing wild-type and Fat1 KO mitochondria isolates with 1% Digitonin and complex resolution using NativePAGE 3-12% Bis-Tris gel electrophoresis (Life Technologies). Second dimension analysis involved reducing and alkylating separated proteins, loading the gel strip onto a 10% Tris-Glycine gel, and performing SDS-PAGE, following by immunoblotting for specific complex components and Fat1. Native Complex I and supercomplex levels were analysed with the Image-J (v1.48v) software. Animal models. Tagln-cre and Fat1 loxP/loxP mice have been described previously 11, 24 . We crossed Tagln-cre (129SV background) and Tagln-cre (Fat1 SMKO ) mice, using a breeding strategy to produce both genotypes within the same litter. Eight to ten week old male mice were studied. All animals were housed in pathogen-free conditions. Procedures followed rules and regulations of the AAALAC, and were approved by the Institutional Animal Care and Use Committee (IACUC) of Albert Einstein College of Medicine. Vascular injury in mice was performed using the carotid artery ligation model, as described previously 25 . Mice were anaesthetized with ketamine/xylazine. The left common carotid artery was ligated with 6-0 suture just proximal to the carotid bifurcation, and the unmanipulated right carotid artery served as a control. Carotid arteries were collected at different time points up to 14 days after ligation. For collection, mice were euthanized with ketamine/xylazine and exsanguination, and the central vasculature was flushed with PBS and perfused with 4% PFA in PBS for 7 min. Arteries were removed, post-fixed with 4% PFA in PBS overnight, processed before being embedded in paraffin, and cross-sectioned (5 μ m thickness) for subsequent studies. Morphometric analysis of arteries was performed using the ImageJ software as follows: the area of the lumen, the area inside the internal elastic lamina, and the area inside the external elastic lamina were measured in pixels, and the areas of the intima and media were calculated. The size of the neointima was expressed as the intima:media ratio. Areas of medial hyperplasia were measured in pixels and expressed as percentage of the total medial area. For immunohisto chemical evaluation, arterial sections were deparaffinized and rehydrated. Endogenous peroxidase activity was neutralized before tissues were boiled in antigen retrieval solution (H-3300, Vector Labs). Sections were then blocked (2% BSA, 10% normal goat serum, and avidin blocking solution (Vector Labs) in PBS), incubated with primary antibody (in 2% BSA, 10% normal goat serum, and biotin blocking solution (Vector Labs) in PBS), incubated with biotinylated secondary antibody (Vector Labs) at a concentration of 1:500, incubated with ABC reagent (PK-6100, Vector Labs), incubated with DAB/substrate/chromagen system (K3467, Dako), and finally, counterstained with haematoxylin (H-3404, Vector Labs). Omission of primary antibodies served as controls for signal specificity, and the samples were imaged using a COOLSCOPE digital microscope (Nikon). For immunofluorescence studies, arterial sections were deparaffinized, rehydrated, and boiled in antigen retrieval solution (H-3300, Vector Labs). Sections were then incubated in blocking solution (0.3% Triton-X-100, 2% BSA, and 10% normal goat serum in PBS) overnight. Primary antibodies were applied in blocking solution, and fluorochrome-conjugated secondary antibodies were applied in 0.3% Triton-X-100, 2% BSA in PBS. Omission of primary antibodies served as controls for signal specificity. The sections were mounted with Fluoro-Gel II (with DAPI) mounting medium (17985-50, Electron Microscope Sciences) and visualized with an Axio Observer.Z1 (Zeiss) fluorescence microscope. Human coronary artery studies. Staining of human coronary artery samples was performed using formalin-fixed paraffin-embedded human coronary artery atherosclerotic plaque sections obtained from the CVPath Institute Sudden Cardiac Death Registry. To evaluate restenotic samples, we chose artery segments adjacent to the site of a bare-metal stent implanted within the preceding 30 days. H&E stain and immunohistochemistry for FAT1 and ACTA2 were performed. The immunohistochemical staining was developed by NovaRED kit (Vector Laboratories, Burlingame, CA). The images were captured by Axio Scan. Z1 (Zeiss, Germany) using a 20× objective, and figures were prepared on the HALO image analysis platform (Indica Labs, Corrales, NM). Antibodies. We used antibodies against Fat1 (ref. 15) (1:10,000 for western blot (WB), 1:2,000 for immunofluorescence (IF), 1:2,000 for immunohistochemistry (IHC)), BiP (1:5,000 for WB, 610979, BD Biosciences), Flag (1:15,000 for WB, F3165, Sigma), cyclin D1 (1:1,000 for WB, 1:200 for IHC, 2978S, Cell Signaling), total OXPHOS cocktail (1:1,000 for WB, ab110413, Abcam), LC3 I/II (1:1,000 for WB, 2775S, Cell Signaling), complex I NDUFA9 (1:1,000 for WB, ab14713, Abcam), complex II 70 kDa Fp subunit (1:10,000 for WB, 459200, Invitrogen), complex III subunit core 1 (1:2,000 for WB, 459140, Invitrogen), complex IV MTCO1 (1:2,000 for WB, ab14705, Abcam), complex V ATP synthase subunit α The following antibodies were from Santa Cruz: complex I NDUFS3 (1:600 for WB, sc374282), c-Myc (1:20,000 for WB, sc789), β -catenin (1:800 for WB, sc7963), PGC1-α (1:150 for WB, sc13067), PGC1-β (1:100 for WB, sc373771), Tfam (1:150 for WB, sc23588), Mfn1 (1:600 for WB, sc50330), Mfn2 (1:600 for WB, sc50331), Acta2 (1:200 for IF, sc32351), nitrotyrosine (1:250 for IF, sc32757), GAPDH (1:8,000 for WB, sc25778), anti-rabbit IgG HRP (1:10,000, sc2030), and anti-goat IgG HRP (1:10,000, sc2056). PCR. RNA was isolated from wild-type and Fat1 KO SMCs with Trizol (Life Technologies), and cDNA was generated using Superscript III (Life Technologies). Quantitative reverse-transcription PCR (qRT-PCR) was performed using the SYBR Green system (Roche) on a Lightcycler 480 instrument (Roche). The relative abundance of each transcript was calculated using the Δ Δ Ct method, with the Rpl13a housekeeping gene as reference. We used the following PCR primers. 
